BriaCell Therapeutics Corp. - *W EXP 02/26/202 (BCTXW)

CUSIP: 10778Y112

Q2 2022 13F Holders as of 30 Jun 2022

Share change
+244,131
SEC-reported price per share
$2.60
Number of holders
7
Value change
+$551,681
Number of buys
4
Number of sells
2

Security key

10778Y112

Report period

Q2 2022

Institutions

7

Top holders

7

Ownership snapshot

Top reported holders of BCTXW - BriaCell Therapeutics Corp. - *W EXP 02/26/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
K.J. Harrison & Partners Inc
Disclosed value leader
K.J. Harrison & Partners Inc
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $14,581,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

K.J. Harrison & Partners Inc has the largest disclosed position value at $14.58M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens K.J. Harrison & Partners Inc's linked filing trail.
Disclosed position value Top 5
K.J. Harrison & Partners Inc $14.58M
Lynwood Capital Management Inc. $7.6M
Leonard Green & Partners, L.P. $5.07M
WASATCH ADVISORS LP $2.48M
Murchinson Ltd. $2.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
K.J. Harrison & Partners Inc
13F
Company
13F
—
mixed-class rows
$14,581,000
1,511,839 shares
mixed-class rows
— 31 Mar 2022
Lynwood Capital Management Inc.
13F
Company
13F
—
denominator unverified
$7,605,000
750,000 shares
— 31 Mar 2022
Leonard Green & Partners, L.P.
13F
Company
13F
—
denominator unverified
$5,070,000
500,000 shares
— 31 Mar 2022
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$2,481,000
244,691 shares
— 31 Mar 2022
Murchinson Ltd.
13F
Company
13F
—
denominator unverified
$2,444,000
469,950 shares
— 31 Mar 2022
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$1,950,000
375,000 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
7
Shares
1,402,413
Rows available
7
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q4 2025 Across Filers

Q4 2025 holders
6
Q2 2022 holders
7
Holder diff
1
Investor Q4 2025 Shares Q2 2022 Shares Share Diff Share Chg % Q4 2025 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .